Genomic Health (GHDX)
Genomic Health Accounts Receivable: 20.84M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
GHDX Accounts Receivable Rankings
| Overall | 30th percentile | 2632 of 3766 |
| Sector | 52nd percentile | 208 of 442 in Healthcare |
| Industry | 47th percentile | 12 of 23 in Medical Laboratories & Research |
GHDX Accounts Receivable Range, Past 5 Years
| Minimum | 3.033M | Jun 2007 |
| Maximum | 22.65M | Sep 2011 |
| Average | 11.68M |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
You may also be interested in these GHDX related companies
GHDX News
NEW POST: "A Bit Too Rare" http://stks.co/3ySS $GENE $GHDX $MYGN $QQQ $ROSG $SPY
about 5 days ago by chessNwine
about 5 days ago by chessNwine
$GHDX Insider Buy: $5.4M of stock bought by Felix Baker between May 21, 2012 - May 22, 2012 http://stks.co/3xjR
about 6 days ago by MarketBrief
about 6 days ago by MarketBrief
$GHDX Insider Buy: $12.7M of stock bought by Felix Baker between May 14, 2012 - May 16, 2012 http://stks.co/3rdD
about 13 days ago by MarketBrief
about 13 days ago by MarketBrief
10 breakouts: $BONA, $GHDX. Two sub-$1 and no penny stocks. Slow day but no focus on weak stocks, just a lack of interest
about 15 days ago by fallondpicks
about 15 days ago by fallondpicks
Genomic Health, Marriott Vacations Worldwide Among Stocks Setting 52-Week Highs Monday
May 14, 4:32PM Fox Business
May 14, 4:32PM Fox Business
$GHDX Another Baker Brothers favorite, crushing it over the last 6 trading days. This kind of move & volume in this crappy market? Whats up?
about 15 days ago by PTSD_Trader
about 15 days ago by PTSD_Trader
Ruparelia's picks in diagnostic testing, robots and 3D printing: $GHDX $IRBT $SSYS $DDD http://stks.co/3nhk
about 16 days ago by covestor
about 16 days ago by covestor
$GHDX I like the volume/accumulation here. Keeping on watch list. New name for me. http://chart.ly/bl5p3dd
about 17 days ago by BrettPerlman
about 17 days ago by BrettPerlman
$GHDX Insider Buy: $3.4M of stock bought by Felix Baker between May 9, 2012 - May 11, 2012 http://stks.co/3nPM
about 18 days ago by MarketBrief
about 18 days ago by MarketBrief
$GHDX Insider Buy: $5.6M of stock bought by Felix Baker between May 4, 2012 - May 8, 2012 http://stks.co/3jWm
about 21 days ago by MarketBrief
about 21 days ago by MarketBrief
Canaccord Genuity Maintains a 'Hold' on Genomic Health (GHDX); Raising PT and Estimates
May 03, 9:44AM Street Insider
May 03, 9:44AM Street Insider
Genomic Health Announces First Quarter 2012 Financial Results and Business Progress
May 02, 4:01PM PR Newswire
May 02, 4:01PM PR Newswire
Genomic Health (GHDX) to Report New Data from Recent Oncotype DX Clinicals
Mar 21, 7:03AM Street Insider
Mar 21, 7:03AM Street Insider
$GHDX http://stks.co/2p6Y Continues to act well on nice price & volume profile. Back near HOD.
about 77 days ago by Fibline
about 77 days ago by Fibline
Baker Bros stake in $GHDX is now over 35% of the whole company. There's really only one way to sell out of a position like that one day.
about 79 days ago by bradloncar
about 79 days ago by bradloncar
RT @ElliotTurn: Best idea from Barron's= $GHDX, w/ Baker Bros. accumulating a massive stake in the provider of personalized genomics-based
about 80 days ago by WallStJesus
about 80 days ago by WallStJesus
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GHDX | 34.67 | +0.11 | +0.32% | 1.036B |
| GGT | 6.72 | +0.08 | +1.20% | |
| GGR | 0.1999 | -0.00 | -0.05% | 19.83M |
| GGP | 17.07 | +0.26 | +1.55% | |
| FRT | 99.42 | +0.83 | +0.84% | 6.277B |
| FRS | 27.18 | -0.04 | -0.15% | 134.47M |
| FRP | 5.39 | -0.13 | -2.36% | |
| FRO | 5.31 | -0.07 | -1.30% | 418.89M |
| FORTY | 16.00 | -0.22 | -1.36% | 226.24M |
| FORR | 33.27 | -0.04 | -0.12% | 755.14M |
